Definitive Contract HDTRA124C0003
Award Date 11/3/23
Potential Completion Date 7/31/26
Potential Value $4.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
STTR Phase III
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a for-profit startup company. The $150,523.52 firm-fixed-price contract is for the development of infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications. Genecapture specializes in rapid pathogen detection solutions using their patented CAPTURE technology. This contract supports DTRA's efforts...
- This is a $1,271,417.59 Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Genecapture, Inc., a for-profit startup company. The contract is for a Small Business Technology Transfer (STTR) Phase II effort focused on developing infectious disease diagnostics and differentiation of viral versus bacterial infections for point-of-care applications. The contract was set aside for small businesses. Genecapture specializes in rapid infectious disease...
- The Defense Health Agency (DHA) awarded a $249,938.77 Small Business Innovation Research (SBIR) Phase I contract to Genecapture, Inc., a for-profit startup company located at the Hudson Alpha Institute for Biotechnology. The contract is for the project titled "Expanding Genecapture's Rapid Portable Invasive Fungal Infection (IFI) Diagnostics for Wound Infections." Genecapture develops rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies...
- This federal contract award, HDTRA117P0016, was issued by the Defense Threat Reduction Agency (DTRA) to Reference Genomics, Inc., a small business contractor, for a Small Business Innovation Research (SBIR) Phase I research project. The $149,871.00 firm fixed-price contract was awarded on March 21, 2017, with an ultimate completion date of October 20, 2017. The contract was set aside for total small business participation. This SBIR Phase I award supports research and development activities...
- This is a $149,877.00 firm fixed price purchase order awarded by the Defense Threat Reduction Agency (DTRA) to Radiant Genomics, Inc., a small disadvantaged business. The contract is for a SBIR Phase I research project. SBIR stands for Small Business Innovation Research, which is a program that provides funding for small businesses to conduct research and development. The contract has a total small business set-aside, meaning it was reserved for small businesses. The period of performance ends...
- This is a $147,976.50 firm fixed-price purchase order awarded by the Defense Threat Reduction Agency (DTRA) to Daktari Diagnostics, Inc., a self-certified small disadvantaged business, for a SBIR Phase I research project. The contract is set aside for small businesses. The work will be performed in Cambridge, MA and the ultimate completion date is October 10, 2017. This SBIR Phase I contract is part of DTRA's broader SBIR program, which provides funding to small businesses for research and...
- This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Optical Biosystems, Inc., a for-profit manufacturer, for a "Rapid Quantitative In-Situ Protein and Gene Expression Platform Technologies for Host Response Biomarker Methods and Analysis" project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, has a ceiling value of $4,487,101.00, and was awarded on December 7, 2017 with an ultimate completion date of...
- The Defense Threat Reduction Agency (DTRA) awarded a Phase I Small Business Innovation Research (SBIR) contract valued at $167,492.11 to Aeris LLC for nucleotide sequencing research and development. This set-aside contract, executed on October 21, 2024, with a completion date of May 20, 2025, represents DTRA's investment in innovative small business capabilities. Aeris LLC, a small business subchapter S corporation based in Louisville, Colorado, was selected as the prime contractor for this...
- Genecapture, Inc. was awarded a definitive contract valued at $1,099,956.91 by the Department of the Army Medical Command to conduct research and development under the Small Business Innovation Research (SBIR) Program Phase II. The contract supports Proposal No. H2-0647 titled "Genecapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens." Research will be conducted in Huntsville, Alabama over a period of performance from September 2021 through January 2024 under...
- The Defense Threat Reduction Agency (DTRA) awarded a $167,494 firm-fixed-price purchase order to Parabon Nanolabs, Inc., a small business, under the SBIR Program Phase I. The contract is for the development of a system to engineer nanocarriers able to transport cargo across the blood-brain barrier. The award has a total small business set-aside designation and is set to be completed by October 26, 2023. Parabon Nanolabs has prior experience providing DNA analysis, forensic, and research and...